Insider · CIK 0001317217

Oracle Associates LLC

CIK 0001317217 Name as filed on the most recent filing

Filed as Oracle Associates LLC (21)

107 transaction lines · from 21 filings · filed 2005-02-11 to 2017-12-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2017-12-05 P, Open-market purchase Biolase, IncBIOL 4,900,000, acquired Open Form 4 filing 0001140361-17-045190
2017-12-04 P, Open-market purchase Biolase, IncBIOL 540,000, acquired Open Form 4 filing 0001140361-17-045190
2017-02-17 P, Open-market purchase Vermillion, Inc.VRML 864,823, acquired Open Form 4 filing 0001140361-17-008151
2015-07-14 P, Open-market purchase Vermillion, Inc.VRML 2 lines 1,003,504, acquired Open Form 4 filing 0001140361-15-027836
2015-05-12 P, Open-market purchase Hansen Medical IncHNSN 3 lines 12,278,637, acquired Open Form 4 filing 0001140361-15-020806
2015-05-12 P, Open-market purchase Hansen Medical IncHNSN 3 lines 12,277,643, acquired Open Form 4 filing 0001140361-15-019836
2014-12-23 P, Open-market purchase Vermillion, Inc.VRML 1,400,000, acquired Open Form 4 filing 0001140361-14-046532
2013-08-08 P, Open-market purchase Hansen Medical IncHNSN 3 lines 9,965,226, acquired Open Form 4 filing 0001140361-13-031174
2008-02-12 S, Open-market sale Access Pharmaceuticals IncACCP 93,668, disposed Open Form 4 filing 0000899140-08-001309
2008-02-12 P, Open-market purchase Access Pharmaceuticals IncACCP 93,668, acquired Open Form 4 filing 0000899140-08-001309
2007-07-24 S, Open-market sale Access Pharmaceuticals IncACCP 8,874, disposed Open Form 4 filing 0000899140-08-001309
2007-07-23 S, Open-market sale Access Pharmaceuticals IncACCP 17,425, disposed Open Form 4 filing 0000899140-08-001309
2007-06-19 S, Open-market sale Access Pharmaceuticals IncACCP 2 lines 310,200, disposed Open Form 4 filing 0000899140-08-001309
2007-06-19 P, Open-market purchase Access Pharmaceuticals IncACCP 310,200, acquired Open Form 4 filing 0000899140-08-001309
2007-03-01 S, Open-market sale Access Pharmaceuticals IncACCP 8,550, disposed Open Form 4 filing 0000899140-08-001309
2007-02-28 S, Open-market sale Access Pharmaceuticals IncACCP 2 lines 102,950, disposed Open Form 4 filing 0000899140-08-001309
2007-02-27 S, Open-market sale Access Pharmaceuticals IncACCP 2 lines 2,800, disposed Open Form 4 filing 0000899140-08-001309
2007-02-26 S, Open-market sale Access Pharmaceuticals IncACCP 3 lines 182,850, disposed Open Form 4 filing 0000899140-08-001309
2007-01-22 S, Open-market sale Access Pharmaceuticals IncACCP 15,281, disposed Open Form 4 filing 0000899140-08-001309
2007-01-22 P, Open-market purchase Access Pharmaceuticals IncACCP 15,281, acquired Open Form 4 filing 0000899140-08-001309
2006-10-26 S, Open-market sale Mediware Information Systems IncMEDW 3 lines 825,000, disposed Open Form 4 filing 0000899140-06-001503
2006-09-01 S, Open-market sale Access Pharmaceuticals IncACCP Not reported Open Form 4 filing 0000899140-08-001309
2006-09-01 S, Open-market sale Access Pharmaceuticals IncACCP Not reported Open Form 4 filing 0000899140-08-001309
2006-09-01 S, Open-market sale Access Pharmaceuticals IncACCP Not reported Open Form 4 filing 0000899140-08-001309
2006-08-09 S, Open-market sale Mediware Information Systems IncMEDW 2 lines 534,960, disposed Open Form 4 filing 0000899140-06-001210
2006-02-17 S, Open-market sale Mediware Information Systems IncMEDW 21,564, disposed Open Form 4 filing 0000899140-06-000312
2006-02-16 S, Open-market sale Mediware Information Systems IncMEDW 4,904, disposed Open Form 4 filing 0000899140-06-000312
2006-01-04 S, Open-market sale Mediware Information Systems IncMEDW 9,864, disposed Open Form 4 filing 0000899140-06-000312
2005-12-31 P, Open-market purchase Access Pharmaceuticals IncACCP 4 lines 309,154, acquired Open Form 4 filing 0000899140-08-001309
2005-09-29 S, Open-market sale Mediware Information Systems IncMEDW 78,400, disposed Open Form 4 filing 0000899140-05-000902
2005-09-29 S, Open-market sale Mediware Information Systems IncMEDW 32,000, disposed Open Form 4 filing 0000899140-05-000902
2005-09-29 S, Open-market sale Mediware Information Systems IncMEDW 23,200, disposed Open Form 4 filing 0000899140-05-000902

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Oracle Associates LLC, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001317217

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.